UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 24, 2023
Accession Number:
0001104659-23-110245
Submission Type:
POS AM
CIK:
0001641640
Company Name:
Nabriva Therapeutics plc
File Number:
333-260146